Search results
Results from the WOW.Com Content Network
The 2010 DePuy Hip Replacement Recall was instituted when DePuy Orthopaedics, Inc., a division of Johnson and Johnson, recalled its ASR XL Acetabular metal-on-metal hip replacement system on August 24, 2010. [1] [2]
The Janssen COVID‑19 vaccine is used to provide protection against infection by the SARS-CoV-2 virus in order to prevent COVID‑19 in people aged eighteen years and older. [ 36][ 1] The vaccine is given by intramuscular injection into the deltoid muscle. The initial course consists of a single dose.
In 2022 J&J informed Emergent of its decision to terminate the deal, citing breaches including failure to supply COVID-19 vaccine drug substance on the part of the contract manufacturer. Emergent ...
The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria[6]and Covishield,[7]is a viral vector vaccine[8]produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. [8][9][10]Finland, Denmark, and Norway suspended the use of the Oxford ...
Johnson & Johnson (NYSE: JNJ) is exploring a plan to offload liabilities from its Baby Powder litigation into a newly created business that would then seek bankruptcy protection, Reuters reports.
Johnson & Johnson. / 40.49861°N 74.44361°W / 40.49861; -74.44361. Johnson & Johnson ( J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones ...
Johnson & Johnson CEO William Weldon (pictured) apologized to Congress Thursday for a series of issues that recently have beset the world's biggest health-products company, specifically the recall ...
In many other countries, DePuy operates as a brand under the Johnson & Johnson Medical organization. [1] DePuy is currently the subject of more than 11,000 lawsuits related to its recall of faulty hip replacement systems, which lawyers and industry analysts estimate will cost parent company Johnson & Johnson billions of dollars to resolve. [2]